CDTX logo

Cidara Therapeutics (CDTX)

Profile

Full Name

Cidara Therapeutics, Inc.

Ticker Symbol

CDTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 15, 2015

Indexes

Not included

Website

http://www.cidara.com

Employees

38

Key Details

Price

$18.63(-2.72%)

Market cap

$233.75M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.27M(-94.52% YoY)

Annual EPS

-$26.75(-409.52% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $18.63
    CDTX price is $18.63

    30-Day Relative Volume

    0.44
    CDTX 30-day relative volume is 0.44

    Price Performance

    Price Most recent change

    -2.72%
    CDTX price was down -2.72% on May 9, 2025

    Price YTD change

    -30.69%
    CDTX price is down -30.69% since January 1st

    Price 1-year change

    +47.86%
    CDTX price is up +47.86% year-on-year

    Price 3-year change

    +27.6%
    CDTX price is up +27.6% over the past 3 years

    Price Range

    Price All-time high

    $382.60
    CDTX price is currently -95.13% below its historical high of $382.60

    Price 3-year low

    $8.00
    CDTX price is currently +132.88% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $233.75M
    CDTX market capitalization is $233.75 million

    Market cap 3-year change

    +363.72%
    CDTX market capitalization is up +363.72% over the past 3 years

    Market cap All-time high

    $301.58M
    CDTX market capitalization is currently -22.49% below its historical high of $301.58 million

    Market cap sector rank

    58.56%
    CDTX market capitalization is higher than 58.56% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +175.04%
    CDTX shares outstanding is up +175.04% year-on-year

    Shares Outstanding 3-Year Change

    +263.41%
    CDTX shares outstanding is up +263.41% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.65
    CDTX beta is 0.65

    200-day SMA

    $17.48
    CDTX price is currently +6.56% above its 200-day simple moving average

    50-day SMA

    $20.91
    CDTX price is currently -10.89% below its 50-day simple moving average

    RSI

    39.70
    CDTX 14-day relative strength index is 39.70

    Volume

    0.44
    CDTX 30-day relative volume is 0.44

    ATR

    $1.55
    CDTX average true range is $1.55

    10-day Historical Volatility

    52.27%
    CDTX 10-day historical volatility is 52.27%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.27M
    CDTX annual revenue is $1.27 million

    Revenue Analysts estimate

    -
    CDTX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -94.52%
    CDTX annual revenue is down -94.52% year-on-year

    Revenue Sector rank

    13.45%
    CDTX annual revenue is higher than 13.45% of companies in Healthcare sector

    EPS

    EPS

    -$26.75
    CDTX annual earnings per share is -$26.75

    EPS Analysts estimate

    -$8.14
    CDTX annual earnings per share is currently +228.52% higher than the consensus analysts' forecast

    EPS 1-year change

    -409.52%
    CDTX annual earnings per share is down -409.52% year-on-year

    EPS Sector rank

    5.51%
    CDTX annual earnings per share is higher than 5.51% of companies in Healthcare sector

    Profit

    Gross profit

    -
    CDTX annual gross profit value is unknown

    Gross margin

    -
    CDTX annual gross profit margin value is unknown

    Operating profit

    -$176.10M
    CDTX annual operating income is -$176.10 million

    Operating margin

    -13.81K%
    CDTX annual operating profit margin is -13.81 thousand%

    Net income

    -$169.83M
    CDTX annual net profit is -$169.83 million

    Net margin

    -13.32K%
    CDTX annual net profit margin is -13.32 thousand%

    Expenses

    Total expenses

    $177.38M
    CDTX annual total expenses is $177.38 million

    Operating expenses

    $177.38M
    CDTX annual total operating expenses is $177.38 million

    Cost of goods sold

    -
    CDTX annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $20.61M
    CDTX annual SGA is $20.61 million

    Depreciation and amortization

    $233.00K
    CDTX annual depreciation & amortization is $233.00 thousand

    Interest expense

    -
    CDTX annual interest expense value is unknown

    Income tax

    $0.00
    CDTX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$176.10M
    CDTX annual earnings before interest & taxes is -$176.10 million

    EBITDA

    -$175.87M
    CDTX annual EBITDA is -$175.87 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $214.80M
    CDTX annual total assets is $214.80 million

    Non current assets

    $4.06M
    CDTX annual long term assets is $4.06 million

    Current assets

    $210.74M
    CDTX annual total current assets is $210.74 million

    Cash and cash equivalents

    $189.82M
    CDTX annual cash & cash equivalents is $189.82 million

    Accounts receivable

    $1.69M
    CDTX annual accounts receivable is $1.69 million

    Inventory

    -
    CDTX annual inventory value is unknown

    Liabilities

    Total liabilities

    $51.49M
    CDTX annual total liabilities is $51.49 million

    Long term liabilities

    $1.93M
    CDTX annual total long term liabilities is $1.93 million

    Current liabilities

    $49.55M
    CDTX annual total current liabilities is $49.55 million

    Accounts payable

    $3.61M
    CDTX annual accounts payable is $3.61 million

    Debt

    Total debt

    $3.58M
    CDTX annual total debt is $3.58 million

    Total debt 1-year change

    -26.68%
    CDTX annual total debt is down -26.68% year-on-year

    Long term debt

    $1.93M
    CDTX annual long term debt is $1.93 million

    Short term debt

    $1.64M
    CDTX annual short term debt is $1.64 million

    Equity & Capital

    Shareholders equity

    $163.31M
    CDTX annual stockholders equity is $163.31 million

    Book value

    $163.31M
    CDTX annual book value is $163.31 million

    Retained earnings

    -$611.26M
    CDTX annual retained earnings is -$611.26 million

    Working capital

    $161.18M
    CDTX annual working capital is $161.18 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$176.53M
    CDTX annual cash flow from operations is -$176.53 million

    Cash from operations 1-year change

    -686.97%
    CDTX annual cash flow from operations is down -686.97% year-on-year

    Cash from investing

    -$129.00K
    CDTX annual cash flow from investing activities is -$129.00 thousand

    Cash from investing 1-year change

    +74.46%
    CDTX annual cash flow from investing activities is up +74.46% year-on-year

    Cash from financing

    $337.06M
    CDTX annual cash flow from financing activities is $337.06 million

    Cash from financing 1-year change

    +1197.19%
    CDTX annual cash flow from financing activities is up +1197.19% year-on-year

    CAPEX

    CAPEX

    $129.00K
    CDTX annual capital expenditures is $129.00 thousand

    CAPEX 1-year change

    -74.46%
    CDTX annual capital expenditures is down -74.46% year-on-year

    Free Cash Flow

    Free cash flow

    -$176.66M
    CDTX annual free cash flow is -$176.66 million

    Free cash flow 1-year change

    -670.21%
    CDTX annual free cash flow is down -670.21% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    CDTX annual gross profit margin value is unknown

    Operating margin

    -13.81K%
    CDTX annual operating profit margin is -13.81 thousand%

    Net margin

    -13.32K%
    CDTX annual net profit margin is -13.32 thousand%

    ROA & ROE

    ROA

    -120.52%
    CDTX annual return on assets is -120.52%

    ROE

    -218.99%
    CDTX annual return on equity is -218.99%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CDTX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CDTX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.43
    CDTX price to book ratio is 1.43

    PB ratio Sector rank

    50.61%
    CDTX price to book ratio is higher than 50.61% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    CDTX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    CDTX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $47.50M
    CDTX enterprise value is $47.50 million

    Enterprise value Sector rank

    42.9%
    CDTX enterprise value is higher than 42.9% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.51
    CDTX EV/EBITDA is -0.51

    EV/EBITDA Sector rank

    53.58%
    CDTX EV/EBITDA is higher than 53.58% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.25
    CDTX annual current ratio is 4.25

    Quick ratio

    -
    CDTX annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    CDTX annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    CDTX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CDTX piotroski f-score value is unknown

    Altman Z-Score

    -3.06
    CDTX altman z-score is -3.06

    Analyst ratings

    Recent major analysts updates

    May 9, 25 JMP Securities
    Market Outperform
    May 9, 25 Guggenheim
    Buy
    Apr 29, 25 JMP Securities
    Market Outperform
    Apr 10, 25 Needham
    Buy
    Mar 12, 25 Citizens Capital Markets
    Market Outperform
    Mar 10, 25 HC Wainwright & Co.
    Buy
    Mar 7, 25 Needham
    Buy
    Dec 13, 24 RBC Capital
    Outperform
    Dec 5, 24 WBB Securities
    Strong Buy
    Nov 11, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with CDTX included

    Growing Shares Outstanding
    US stocks
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Earnings this week
    • What is the ticker symbol for Cidara Therapeutics?
    • Does Cidara Therapeutics pay dividends?
    • What sector is Cidara Therapeutics in?
    • What industry is Cidara Therapeutics in?
    • What country is Cidara Therapeutics based in?
    • When did Cidara Therapeutics go public?
    • Is Cidara Therapeutics in the S&P 500?
    • Is Cidara Therapeutics in the NASDAQ 100?
    • Is Cidara Therapeutics in the Dow Jones?
    • When was Cidara Therapeutics's last earnings report?
    • When does Cidara Therapeutics report earnings?
    • Should I buy Cidara Therapeutics stock now?

    What is the ticker symbol for Cidara Therapeutics?

    The ticker symbol for Cidara Therapeutics is NASDAQ:CDTX

    Does Cidara Therapeutics pay dividends?

    No, Cidara Therapeutics does not pay dividends

    What sector is Cidara Therapeutics in?

    Cidara Therapeutics is in the Healthcare sector

    What industry is Cidara Therapeutics in?

    Cidara Therapeutics is in the Biotechnology industry

    What country is Cidara Therapeutics based in?

    Cidara Therapeutics is headquartered in United States

    When did Cidara Therapeutics go public?

    Cidara Therapeutics's initial public offering (IPO) was on April 15, 2015

    Is Cidara Therapeutics in the S&P 500?

    No, Cidara Therapeutics is not included in the S&P 500 index

    Is Cidara Therapeutics in the NASDAQ 100?

    No, Cidara Therapeutics is not included in the NASDAQ 100 index

    Is Cidara Therapeutics in the Dow Jones?

    No, Cidara Therapeutics is not included in the Dow Jones index

    When was Cidara Therapeutics's last earnings report?

    Cidara Therapeutics's most recent earnings report was on May 8, 2025

    When does Cidara Therapeutics report earnings?

    The date for Cidara Therapeutics's next earnings report has not been announced yet

    Should I buy Cidara Therapeutics stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page